Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Isis Pharmaceuticals Inc (NASDAQ:ISIS)

Wednesday’s trading has closed, but ISIS is being traded in the after-hours session. After-Hours quote »
51.75
Delayed Data
As of 3:59pm ET
 +3.00 / +6.15%
Today’s Change
35.26
Today|||52-Week Range
77.80
-16.18%
Year-to-Date
No recent news for Isis Pharmaceuticals Inc.

Today’s Trading

Previous close48.75
Today’s open49.05
Day’s range48.65 - 51.81
Volume1,634,898
Average volume (3 months)2,219,039
Market cap$5.8B
Dividend yield--
Data as of 3:59pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)+40.00%
Earnings growth (this year)-33.61%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+45.41%
P/E ratio268.7
Price/Sales33.93
Price/Book22.40

Competitors

 Today’s
change
Today’s
% change
ICLRICON PLC+1.13+1.51%
PRXLPAREXEL Internationa...+0.94+1.48%
ALNYAlnylam Pharmaceutic...+3.72+3.80%
DYAXDyax Corp+0.99+4.49%
Data as of 3:59pm ET, 09/02/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$214.2M
Annual profit (last year)-$39.0M
Net profit margin-18.20%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer, Secretary &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts

Partner Offers